Table 2.
Full Sample, no MOUD before Index Overdose (n = 4898) | Index Overdose Involved Heroin and/or Synthetic Opioidsa (n = 3541) | Index Overdose Involved Prescription Opioids Onlyb (n = 1357) | |
---|---|---|---|
| |||
Covariate | HR (95% CI) | HR (95% CI) | HR (95% CI) |
MOUD After Overdose | 0.35 (0.24, 0.51)* | 0.30 (0.20, 0.46)* | 0.71 (0.31, 1.62) |
Index Overdose Characteristics | |||
Involved Heroin/Synthetic Opioids | 1.44 (1.22, 1.71)* | – | – |
Involved Benzodiazepines | 0.97 (0.70, 1.35) | 1.06 (0.68, 1.64) | 0.95 (0.57, 1.58) |
Resulted in Inpatient Hospitalization | 0.75 (0.63, 0.9)* | 0.78 (0.64, 0.96)* | 0.70 (0.49, 1.00)* |
Age | |||
12–24 | 1.26 (0.93, 1.71) | 1.25 (0.89, 1.76) | 1.08 (0.53, 2.19) |
25–39 | 1.24 (0.97, 1.57) | 1.12 (0.85, 1.47) | 1.57 (0.95, 2.58) |
40–55 | 1.02 (0.81, 1.27) | 0.92 (0.70, 1.19) | 1.36 (0.86, 2.12) |
56–64 | REF | REF | REF |
Racial/Ethnic Group | |||
White | REF | REF | REF |
Black | 0.88 (0.74, 1.04) | 0.81 (0.67, 0.99) | 1.14 (0.80, 1.62) |
Hispanic | 0.87 (0.68, 1.10) | 0.77 (0.58, 1.02) | 1.22 (0.74, 1.99) |
Other/Unknown | 0.92 (0.72, 1.17) | 0.99 (0.76, 1.28) | 0.69 (0.37, 1.30) |
Gender | |||
Female | REF | REF | REF |
Male | 1.25 (1.08, 1.43)* | 1.25 (1.07, 1.47) | 1.19 (0.87, 1.62) |
Year of index overdose | |||
2015 | REF | REF | REF |
2016 | 1.11 (0.9, 1.37) | 1.06 (0.84, 1.34) | 1.33 (0.83, 2.11) |
2017 | 1.16 (0.95, 1.42) | 1.09 (0.87, 1.36) | 1.43 (0.91, 2.25) |
2018 | 1.08 (0.88, 1.33) | 1.04 (0.82, 1.31) | 1.26 (0.77, 2.05) |
SUD Comorbiditiesc | |||
Alcohol Use Disorder | 1.03 (0.88, 1.21) | 0.99 (0.83, 1.19) | 1.3 (0.90, 1.90) |
Benzodiazepine Use Disorder | 1.05 (0.82, 1.35) | 1.12 (0.85, 1.46) | 0.76 (0.41, 1.43) |
Cannabis Use Disorder | 0.96 (0.78, 1.18) | 1.04 (0.83, 1.29) | 0.6 (0.32, 1.12) |
Opioid Use Disorder | 1.53 (1.32, 1.77)* | 1.46 (1.24, 1.73) | 1.71 (1.22, 2.39)* |
Psychiatric Comorbiditiesc | |||
Bipolar Disorder | 0.97 (0.8, 1.17) | 0.95 (0.77, 1.17) | 1.17 (0.76, 1.80) |
Major Depressive Disorder | 1.11 (0.94, 1.31) | 1.08 (0.90, 1.31) | 1.16 (0.81, 1.67) |
Anxiety Disorder | 1.00 (0.85, 1.19) | 1.00 (0.83, 1.21) | 1.05 (0.71, 1.54) |
Personality Disorder | 1.13 (0.84, 1.54) | 1.32 (0.95, 1.82) | 0.52 (0.20, 1.31) |
Schizophrenia | 1.04 (0.8, 1.36) | 1.02 (0.76, 1.38) | 1.09 (0.60, 1.98) |
Medical Comorbiditiesc | |||
Chronic Pain | 1.09 (0.94, 1.27) | 1.07 (0.91, 1.26) | 1.26 (0.87, 1.83) |
Heart Failure | 0.83 (0.56, 1.23) | 0.71 (0.42, 1.20) | 1.01 (0.53, 1.96) |
Hepatitis C | 1.16 (0.97, 1.38) | 1.09 (0.90, 1.32) | 1.58 (1.06, 2.37)* |
HIV | 1.26 (0.90, 1.77) | 1.19 (0.80, 1.77) | 1.30 (0.66, 2.58) |
Hypertension | 1.14 (0.96, 1.34) | 1.16 (0.96, 1.41) | 1.00 (0.70, 1.44) |
Pneumonia | 1.22 (0.93, 1.59) | 1.24 (0.91, 1.69) | 1.16 (0.67, 2.03) |
Prescriptions Before Overdose | |||
Benzodiazepines (BZ) | |||
BZ in 6-month baseline | 0.96 (0.76, 1.22) | 1.04 (0.80, 1.35) | 0.73 (0.41, 1.31) |
BZ at index overdose | 1.10 (0.89, 1.36) | 0.93 (0.72, 1.20) | 1.57 (1.04, 2.36)* |
Prescription Opioids | |||
Opioids in 6-month baseline | 0.88 (0.74, 1.04) | 0.96 (0.79, 1.15) | 0.57 (0.37, 0.89)* |
Opioids at index overdose | 0.68 (0.54, 0.86)* | 0.70 (0.53, 0.93)* | 0.59 (0.39, 0.90)* |
Health Service Utilization | |||
ED visit in 6-month baseline | 1.31 (1.13, 1.52)* | 1.33 (1.13, 1.57)* | 1.20 (0.85, 1.68) |
Any psychosocial service in 6-month baseline | 0.84 (0.71, 0.99)* | 0.87 (0.73, 1.05) | 0.66 (0.45, 0.97)* |
Note. CI = confidence interval; SUD = substance use disorder.
Statistically significant at p < 0.05.
Includes opioid poisonings with ICD-9 or ICD-10 codes for heroin or synthetic opioid poisoning, even if codes for methadone or other natural/semi-synthetic opioid poisoning were also present.
Includes opioid poisonings without ICD-9 or ICD-10 codes for heroin or synthetic opioid poisoning.
Reference for each comorbid condition is the absence of the condition.